MDxHealth SA Furnishes Press Release via 6-K Filing
Ticker: MDXH · Form: 6-K · Filed: Feb 16, 2024 · CIK: 1872529
| Field | Detail |
|---|---|
| Company | Mdxhealth SA (MDXH) |
| Form Type | 6-K |
| Filed Date | Feb 16, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K filing, press release, foreign private issuer
TL;DR
**MDxHealth SA just dropped a 6-K with a press release, but the details aren't in this filing.**
AI Summary
MDxHealth SA, a foreign private issuer, filed a Form 6-K on February 16, 2024, to furnish a press release issued on the same date. The company, based in Herstal, Belgium, operates under the Commission File Number 001-40996 and files annual reports under Form 20-F. The press release, attached as Exhibit 99.1, is furnished for informational purposes and is not considered "filed" under Section 18 of the Securities Exchange Act of 1934.
Why It Matters
This filing indicates MDxHealth SA is providing new public information, which could impact investor perception and market activity, even though the specific content of the press release isn't detailed here.
Risk Assessment
Risk Level: low — This filing is purely administrative, indicating the furnishing of a press release without disclosing its content, thus posing minimal direct risk.
Key Players & Entities
- MDxHealth SA (company) — registrant
- February 16, 2024 (date) — filing date and press release date
- 001-40996 (other) — Commission File Number
- Herstal, Belgium (other) — principal executive office location
- Section 18 (other) — Securities Exchange Act of 1934 section
FAQ
What is the purpose of MDxHealth SA's 6-K filing on February 16, 2024?
The purpose of MDxHealth SA's 6-K filing on February 16, 2024, is to furnish a press release issued on the same date, which is attached as Exhibit 99.1.
Under which form does MDxHealth SA file its annual reports?
MDxHealth SA indicates that it files its annual reports under Form 20-F.
What is the Commission File Number for MDxHealth SA?
The Commission File Number for MDxHealth SA is 001-40996.
Is the information in Exhibit 99.1 considered 'filed' for the purposes of the Securities Exchange Act of 1934?
No, the information in the attached Exhibit 99.1 is being furnished and shall not be deemed 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934.
Where is MDxHealth SA's principal executive office located?
MDxHealth SA's principal executive office is located at CAP Business Center, Zone Industrielle des Hauts-Sarts, 4040 Herstal, Belgium.
Filing Stats: 272 words · 1 min read · ~1 pages · Grade level 13.4 · Accepted 2024-02-16 16:05:33
Filing Documents
- ea193939-6k_mdxhealth.htm (6-K) — 10KB
- ea193939ex99-1_mdxhealth.htm (EX-99.1) — 4KB
- ex99-1_001.jpg (GRAPHIC) — 3KB
- 0001213900-24-014899.txt ( ) — 19KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MDXHEALTH SA Date: February 16, 2024 By: /s/ Michael McGarrity Name: Michael McGarrity Title: Chief Executive Officer 2